"Transferable market exclusivity" is an idea the pharmaceutical industry is considering as a solution to the R&D gap in neglected diseases. In this article, published in Scrip World Pharmaceutical News, Elizabeth Sukkar explores its potential role.
First published in issue 3030 of Scrip World Pharmaceutical News
Copyright T&F Informa UK Ltd 2005
Reprinted with permission of PJB Publications